Assessing the acceptability of a novel dry powder inhaler: A multicentre study in adult asthmatic patients using routine bronchodilator therapy
Objective: To assess patient acceptability of a novel dry powder inhaler (DPI), Clickhaler® (Innovata Biomed Ltd., the Respiratory Division of ML Laboratories PLC) in routine clinical use as a first-line bronchodilator treatment. Design: In a multicentre open label study, asthma patients taking bron...
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2001
|